Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation (Q43762654)

26 November 2017

Reduced NAA in the thalamus and altered membrane and glial metabolism in schizophrenic patients detected by 1H-MRS and tissue segmentation (English)

1 reference

26 November 2017

0 references

0 references

1

1 reference

26 November 2017

M Wilke

2

1 reference

26 November 2017

A Grabner

3

1 reference

26 November 2017

J O Heidenreich

4

1 reference

26 November 2017

T Bronisch

5

1 reference

26 November 2017

T C Wetter

6

1 reference

26 November 2017

language of work or name

English

0 references

publication date

1 October 2001

1 reference

26 November 2017

Schizophrenia Research

1 reference

26 November 2017

52

1 reference

26 November 2017

1-2

1 reference

26 November 2017

87-99

1 reference

Thalamic abnormalities in schizophrenia visualized through magnetic resonance image averaging.

26 November 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Multimodal image coregistration and partitioning--a unified framework.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Reduced glutamate in the anterior cingulate cortex in depression: an in vivo proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Quantitative proton spectroscopy of canine brain: in vivo and in vitro correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Proton magnetic resonance spectroscopy in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Regionally specific pattern of neurochemical pathology in schizophrenia as assessed by multislice proton magnetic resonance spectroscopic imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Regionally specific neuronal pathology in untreated patients with schizophrenia: a proton magnetic resonance spectroscopic imaging study.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Quantitative proton-decoupled 31P MRS of the schizophrenic brain in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

PET and MRI of the thalamus in never-medicated patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

1H-magnetic resonance spectroscopy of the left temporal and frontal lobes in schizophrenia: clinical, neurodevelopmental, and cognitive correlates.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Neurochemical alterations in asymptomatic abstinent cocaine users: a proton magnetic resonance spectroscopy study

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Schizophrenia and anteroventral thalamic nucleus: selective decrease of parvalbumin-immunoreactive thalamocortical projection neurons.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Reversible decreases in N-acetylaspartate after acute brain injury

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Reduced concentrations of thalamic N-acetylaspartate in male patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Relative concentrations of proton MR visible neurochemicals in gray and white matter in human brain.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Essential fatty acids, lipid membrane abnormalities, and the diagnosis and treatment of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Proton magnetic resonance spectroscopy of basal ganglia in chronic schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Proton magnetic resonance spectroscopy of the left medial temporal and frontal lobes in chronic schizophrenia: preliminary report.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

The neuropathology of schizophrenia. A critical review of the data and their interpretation

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Regional proton magnetic resonance spectroscopy in schizophrenia and exploration of drug effect.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Fatty acid levels in the brains of schizophrenics and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

The membrane hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

In vivo neurochemistry of the brain in schizophrenia as revealed by magnetic resonance spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Proton magnetic resonance spectroscopic imaging of cortical gray and white matter in schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Compromised white matter tract integrity in schizophrenia inferred from diffusion tensor imaging.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Sensory gating mechanisms of the thalamus

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

A review of chemical issues in 1H NMR spectroscopy: N-acetyl-L-aspartate, creatine and choline

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

In vivo 1H MRS choline: correlation with in vitro chemistry/histology

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Alzheimer disease: depiction of increased cerebral myo-inositol with proton MR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Phospholipid bilayer contribution to 31P NMR spectra in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

In vitro 1H-magnetic resonance spectroscopy of postmortem brains with schizophrenia.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Human brain tumors: assessment with in vivo proton MR spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Pronounced reduction of total neuron number in mediodorsal thalamic nucleus and nucleus accumbens in schizophrenics.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Increased platelet membrane lysophosphatidylcholine in schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Alterations in brain high-energy phosphate and membrane phospholipid metabolism in first-episode, drug-naive schizophrenics. A pilot study of the dorsal prefrontal cortex by in vivo phosphorus 31 nuclear magnetic resonance spectroscopy.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Estimation of metabolite concentrations from localized in vivo proton NMR spectra

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Assessment of brain connectivity in schizophrenics and healthy subjects with diffusion tensor imaging

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

On the reliability of quantitative clinical magnetic resonance spectroscopy of the human brain

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Inositol levels are decreased in postmortem brain of schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

N-acetylaspartate in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Proton nuclear magnetic resonance spectroscopy unambiguously identifies different neural cell types.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

31Phosphorus magnetic resonance spectroscopy of the dorsolateral prefrontal region in schizophrenics--a study including 50 patients and 36 controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Localized phosphorus 31 magnetic resonance spectroscopy in chronic schizophrenic patients and normal controls.

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

Frontal, temporal, and striatal proton relaxation times in schizophrenic patients and normal comparison subjects

1 reference

https://api.crossref.org/works/10.1016%2FS0920-9964%2801%2900155-4

7 January 2021

10.1016/S0920-9964(01)00155-4

Identifiers

DOI

1 reference

26 November 2017

1 reference